The Patent Finder

Chroma Therapeutics Ltd.

Also on record
Records under this name other than patents Chroma Therapeutics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Chroma Therapeutics Ltd.

PatentTitleStatus Expires Confidence
US 7,932,246Histone Deacetylase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,962,825Hydroxamates as Inhibitors of Histone Deacetylase
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,973,181Hydroxamic Acid Derivatives as Inhibitors of Hdac Enzymatic Activity
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,128,086Detection of histone modification in cell-free nucleosomes
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,778,953Inhibitors of P38 Map Kinase
Formerly held
Lapsed on the fee record
Ended Jul 15, 2026 · High confidence
Lapsed on the fee recordEnded Jul 15, 2026High confidence
US 9,896,417Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof
Formerly held
Lapsed on the fee record
Ended Feb 20, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 20, 2026From the USPTO record
US 10,408,831Detection of histone modification in cell-free nucleosomes
Formerly held
Term ended
Ended no later than Aug 18, 2024 · From the USPTO record
Term endedEnded no later than Aug 18, 2024From the USPTO record
US 9,388,136Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof
Formerly held
Lapsed on the fee record
Ended Jul 12, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jul 12, 2024From the USPTO record
US 8,044,211P38 MAP kinase inhibitors
Formerly held
Lapsed on the fee record
Ended Oct 25, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 25, 2023From the USPTO record
US 9,133,104Enzyme inhibitors
Lapsed on the fee record
Ended Sep 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 15, 2023From the USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited